Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | CASP1 | P29466 | 4/20 | 0.43 |
| ▸ | CASP7 | P55210 | 2/20 | 0.43 |
| ▸ | HBB | P68871 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1771699 | 0.84 | ALDH1A1 (0.45) | MEN1KMT2AUSP2RAB9ARXFP1 | |
| SCHEMBL5894181 | 0.78 | ATM (0.40) | MEN1KMT2AUSP2RAB9AALDH1A1 | |
| SCHEMBL5782822 | 0.76 | CYP2A6 (0.45) | MEN1KMT2AALDH1A1ALOX15TDP1 | |
| SCHEMBL1771117 | 0.76 | TNNI3 (0.47) | MEN1KMT2ARAB9AALDH1A1CYP3A4 | |
| SCHEMBL2107267 | 0.76 | CYP1A2 (0.45) | RAB9AALDH1A1KDM4EMAPTHTT | |
| SCHEMBL2088214 | 0.76 | CYP2A6 (0.45) | MEN1KMT2AALDH1A1MAPTHTT | |
| SCHEMBL758788 | 0.76 | CYP2A6 (0.45) | MEN1KMT2ARXFP1ALDH1A1TDP1 | |
| SCHEMBL9531 | 0.73 | ATM (0.48) | ATMACHEBCHE | |
| SCHEMBL1000462 | 0.73 | LCK (0.43) | MEN1KMT2AALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL14742904 | 0.72 | ATM (0.54) | MEN1KMT2ARAB9AALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119285594-A | 7-Aminobenzopyrone or 7-aminoquinolinone compound and application thereof | 浙江大学金华研究院 | 2025-01-10 | — | — | CN | claimed |
| CN-111732573-B | Quinolone acid-aminopyrimidine compound and preparation method and application thereof | 复旦大学 | 2022-09-16 | — | — | CN | claimed |
| CN-111732573-A | Quinolone acid-aminopyrimidine compound and preparation method and application thereof | 复旦大学 | 2020-10-02 | — | — | CN | claimed |
| US-20150157621-A1 | THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING THE SAME | MARIPOSA HEALTH LTD (AU) | 2015-06-11 | — | — | US | claimed |
| US-8980914-B2 | Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same | MARIPOSA HEALTH LIMITED (AU) | 2015-03-17 | — | — | US | claimed |
| US-20100079635-A1 | OPTICAL ELEMENT WAFER MODULE, OPTICAL ELEMENT MODULE, METHOD FOR MANUFACTURING OPTICAL ELEMENT MODULE, ELECTRONIC ELEMENT WAFER MODULE, METHOD FOR MANUFACTURING ELECTRONIC ELEMENT MODULE, ELECTRONIC ELEMENT MODULE AND ELECTRONIC INFORMATION DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2010-04-01 | — | — | US | claimed |
| CN-1902057-A | Optical recording medium and dye | MITSUBISHI CHEM CORP (JP) | 2007-01-24 | — | — | CN | claimed |
| US-20060235045-A1 | Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-10-19 | — | — | US | claimed |
| EP-1650191-A1 | THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD OF TREATMENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH THE SAME | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-04-26 | — | — | EP | claimed |
| US-6114352-A | Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2000-09-05 | — | — | US | claimed |
| EP-0785190-B1 | Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK & CHEMICALS (JP) | 2000-08-16 | — | — | EP | claimed |
| US-5942521-A | Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1999-08-24 | — | — | US | claimed |
| EP-0785190-A2 | Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1997-07-23 | — | — | EP | claimed |
| CN-119285594-A | 7-Aminobenzopyrone or 7-aminoquinolinone compound and application thereof | 浙江大学金华研究院 | 2025-01-10 | — | — | CN | disclosed |
| CN-119285594-A | 7-Aminobenzopyrone or 7-aminoquinolinone compound and application thereof | 浙江大学金华研究院 | 2025-01-10 | — | — | CN | disclosed |
| CN-119285594-A | 7-Aminobenzopyrone or 7-aminoquinolinone compound and application thereof | 浙江大学金华研究院 | 2025-01-10 | — | — | CN | disclosed |
| EP-0304087-B1 | Quinolone and naphthyridine antibacterial agents containing an alpha-amino acid in the side chain of the 7-substituent | WARNER LAMBERT CO (US) | 1994-03-30 | — | — | EP | disclosed |
| US-4851418-A | Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent | WARNER-LAMBERT COMPANY (US) | 1989-07-25 | — | — | US | disclosed |
| EP-0304087-A2 | Quinolone and naphthyridine antibacterial agents containing an alpha-amino acid in the side chain of the 7-substituent | WARNER-LAMBERT COMPANY (US) | 1989-02-22 | — | — | EP | disclosed |
| US-4496481-A | REACTING AMINE, COUPLING COMPONENT AND NITRITE;PIGMENTS AND DISPERSE DYES | CIBA-GEIGY CORPORATION (US) | 1985-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235045-A1 | Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same | ELANE, CFTR, ARG2 | MEN1 4882/4885KMT2A 3961/4885USP2 3349/4885 |
| US-20150157621-A1 | THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING THE SAME | ELANE, ARG2, CFTR | MEN1 4882/4885KMT2A 3814/4885USP2 3269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.